Why the study?
Type 2 diabetes is associated with reduced thoracic aortic aneurysm prevalence, and GLP-1 protects against aortic aneurysms in animals, prompting assessment of whether T2D alters inflammatory profiles and relates to fasting GLP-1.
Does Type 2 diabetes alter the inflammatory profile and GLP-1 levels in a manner that supports the reduced prevalence of thoracic aortic aneurysm?
Does Type 2 diabetes alter the inflammatory profile and GLP-1 levels in a manner that supports the reduced prevalence of thoracic aortic aneurysm?
Type 2 diabetes is associated with a Th2 inflammatory shift and elevated fasting GLP-1, which may mechanistically contribute to the reduced prevalence of thoracic aortic aneurysms in this population.
May suggest GLP-1 protection against thoracic aortic aneurysms in diabetes; leaves open causal confirmation and therapeutic implications.
Glucagon-like peptide-1 (GLP-1) regulates processes involved in the pathophysiology of thoracic aortic aneurysms (TAAs), including inflammation, while protecting against aortic aneurysms in animal models. Type 2 diabetes (T2D) involves altered GLP-1 signaling due to pathology and/or therapy and is associated with reduced prevalence of TAAs. We aimed to assess whether T2D alters the inflammatory profile/proteolytic activity, possible correlations to elevated fasting GLP-1 (F-GLP-1), and its relevance for TAA. F-GLP-1, pro-inflammatory T helper 1 (Th1) cytokines, Th2 cytokines, C-reactive protein, and matrix metalloproteinase-2 activity (MMP-2) were analyzed in surgical patients with aortic valve pathology with/without T2D and without T2D but with TAA. Patients with T2D displayed an increase in the relative systemic expression of interleukin 6 and tumor necrosis factor α and a clear trend towards reduced levels of interferon γ (IFNγ). In addition, a positive association between GLP-1 and the plasma interleukin 4 (IL-4)/IFNγ ratio was detected. TAA was associated with significantly lower plasma levels of the Th2 cytokines IL-4 and interleukin 5. Plasma MMP-2 activity did not differ between groups. We conclude that T2D involved a Th2 shift, which associates with elevated F-GLP-1 and may-considering Th1 bias in TAA-contribute to reduced prevalence of TAA in T2D.
No takes yet. Share an insight, caveat, or question.
Ntika et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: